Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
The Journal of Experimental Medicine|December 6, 2024
Antiviral immunity lassoed down by excess RNAErika Valeri, Anna Kajaste-Rudnitski
Gene Therapy|July 15, 2020
Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineeringFrancesco Piras, Anna Kajaste-Rudnitski
Human Gene Therapy|March 27, 2015
Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cellsAnna Kajaste-Rudnitski, Luigi Naldini
Human Gene Therapy|September 6, 2023
Understanding and Tackling Immune Responses to Adeno-Associated Viral VectorsHelena Costa-Verdera, Carmen Unzu, Erika Valeri, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 7, 2013
Lipid-based nanoparticles as nonviral gene delivery vectorsDaniele Pezzoli, Anna Kajaste-Rudnitski, Roberto Chiesa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 24, 2025
Chimeric enzymes enhance treatment potential for globoid cell leukodystrophy through hematopoietic stem cell gene therapyFederica Cascino, Alessandra Ricca, Ilaria Picciotti, et al.
Cell Stem Cell|May 5, 2023
Genetic engineering meets hematopoietic stem cell biology for next-generation gene therapySamuele Ferrari, Erika Valeri, Anastasia Conti, et al.
STAR Protocols|March 7, 2023
Protocol to differentiate monolayer human induced pluripotent stem cells into inflammatory responsive astrocytesAnna Maria Sole Giordano, Monah Abou Alezz, Ivan Merelli, et al.
Amino Acids|November 28, 2009
Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5 alpha and 22Anna Kajaste-Rudnitski, Cinzia Pultrone, Flavia Marzetta, et al.
The Journal of Biological Chemistry|December 24, 2005
The 2',5'-oligoadenylate synthetase 1b is a potent inhibitor of West Nile virus replication inside infected cellsAnna Kajaste-Rudnitski, Tomoji Mashimo, Marie-Pascale Frenkiel, et al.
Pageof 5